RESEARCH NEWS
PHA Offers New Research Grant
The Pulmonary Hypertension Association (PHA) is accepting applications for its new Innovation Research Award. The award supports new areas of pulmonary hypertension research that couldn’t have been explored without PHA funding. Any areas of innovative pulmonary hypertension research will be accepted. Up to $60,000 a year for two years is available.
PAH Trial Participants Inspire Doctor’s Passion for PH Research
Nadine Al-Naamani, M.D., was inspired to become a doctor after growing up in Beirut during the civil war in Lebanon. She knew then that she wanted to help people around her. Today, she treats people with pulmonary hypertension (PH) and other serious lung conditions at Penn Medicine and conducts PH research. She is an assistant professor of medicine at University of Pennsylvania Hospital, a Pulmonary Hypertension Association-accredited PH Care Center. She originally shared her story with Pathlight, PHA’s quarterly member magazine.
Help Advance PH Research
Researchers: It’s not too late to participate in the PHA 2022 Research Room. Five research teams will have a rare opportunity to collect data and biological specimens from the largest gathering of pulmonary hypertension patients. Apply by April 3 to conduct your research at the Pulmonary Hypertension Association’s International PH Conference and Scientific Sessions, June 10-12, Atlanta.
Junior Investigators: Make an Impact on PAH Research
The Pulmonary Hypertension Association is offering a two-year grant for junior investigators interested in pulmonary arterial hypertension (PAH) research. The Aldrighetti Award for Young Investigators, supported by a partnership with Janssen Pharmaceuticals, covers salaries and/or supplies up to $40,000 each year.
PHA Journal: How PAH Affects Organs, Obesity, Other Diseases
The latest issue of Advances in Pulmonary Hypertension addresses pulmonary arterial hypertension (PAH) as a systemic disease. “Even in its purest form, the idiopathic or hereditary PAH, the rest of the body is affected when various organs begin suffering from inadequate perfusion, initially with exertion, then even at rest,” says guest editor Ioana R. Preston, M.D. “Even in its purest form, the idiopathic or hereditary PAH, the rest of the body is affected when various organs begin suffering from inadequate perfusion, initially with exertion, then even at rest,” says guest editor Ioana R. Preston, M.D.
Missed Our Research Room Webinar? Here’s Our Recap
A recent Pulmonary Hypertension Association (PHA) webinar unveiled learnings from six studies conducted at PHA 2108 International PH Conference and Scientific Sessions. Doctors shared updates about the studies in the July 29 PHA Live webinar “PHA Research Room Findings.” More than 200 patients and healthy subjects participated in Research Room 2018, sharing data and biological samples with 10 research teams.
Advances in Pulmonary Hypertension
Read the latest issue of Advances in Pulmonary Hypertension, PHA’s quarterly medical journal.